The FDA approved a new ketamine (KETARx, PharmaTher) for the treatment of surgical pain management. The FDA previously issued a pair of complete response letters for the application in 2024, citing ...

More than half of patients prescribed medical cannabis for chronic musculoskeletal pain stop using it within a year, ...

Who is the ketamine queen that sold fatal drug, causing Matthew Perry death? Here's what to know about ketamine and why ...

A major Cochrane review found no convincing evidence that ketamine or similar NMDA-blocking drugs improve chronic non-cancer ...

A sweeping review of 67 trials has cast doubt on the use of ketamine and similar NMDA receptor antagonists for chronic pain ...

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.

The trouble with many drugs is that they go where they shouldn't, producing unwanted side effects. Psychiatric drugs might ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a ...

The off-label use of ketamine to treat chronic pain is not supported by scientific evidence, a new Cochrane review has found.

Researchers cautioned that the existing evidence base is too poor to draw any solid conclusions on whether ketamine can help ...

NMDA receptor antagonists are a group of medicines that affect the excitability of nerves involved in pain and other brain functions. They include ketamine, memantine, dextromethorphan, amantadine, ...